Back to Resource Hub Article

Leveraging Ecological Momentary Assessment in Depression Trials

In a 6-week trial, 36 participants with major depressive disorder (MDD) used ecological momentary assessment (EMA) to self-report symptoms twice daily. Strong correlations between EMA-derived HamD6 scores and clinician ratings were found, with EMA showing significant improvements over time. Treatment responses from EMA matched clinician ratings in 91.7% of cases. These findings suggest that EMA can provide more accurate, daily tracking of depression symptoms, offering a promising alternative to traditional assessments in clinical trials. 

Similar posts

Looking for more insights? Explore related resources.

CASE STUDY

Signant's Central Rating Services Improved Signal Detection in 5 Major Depressive Disorder Trials

READ THE STUDY
BLOG POST

Endpoint Reliability Solutions for Vineland-3 Scale

VISIT THE BLOG
BROCHURE

Rater Training & Qualification

SEE THE BROCHURE

Get notified on new marketing insights

Here mention the benefits of subscribing